Research ArticleBrain
Open Access
Longitudinal Restriction Spectrum Imaging Is Resistant to Pseudoresponse in Patients with High-Grade Gliomas Treated with Bevacizumab
P.D. Kothari, N.S. White, N. Farid, R. Chung, J.M. Kuperman, H.M. Girard, A. Shankaranarayanan, S. Kesari, C.R. McDonald and A.M. Dale
American Journal of Neuroradiology September 2013, 34 (9) 1752-1757; DOI: https://doi.org/10.3174/ajnr.A3506
P.D. Kothari
aFrom the School of Medicine (P.D.K.)
N.S. White
bDepartments of Radiology (N.S.W., N.F., R.C., J.M.K., A.M.D.)
eMultimodal Imaging Laboratory (N.S.W., N.F., J.M.K., H.M.G., C.R.M., A.M.D.)
N. Farid
bDepartments of Radiology (N.S.W., N.F., R.C., J.M.K., A.M.D.)
eMultimodal Imaging Laboratory (N.S.W., N.F., J.M.K., H.M.G., C.R.M., A.M.D.)
R. Chung
bDepartments of Radiology (N.S.W., N.F., R.C., J.M.K., A.M.D.)
J.M. Kuperman
bDepartments of Radiology (N.S.W., N.F., R.C., J.M.K., A.M.D.)
eMultimodal Imaging Laboratory (N.S.W., N.F., J.M.K., H.M.G., C.R.M., A.M.D.)
H.M. Girard
eMultimodal Imaging Laboratory (N.S.W., N.F., J.M.K., H.M.G., C.R.M., A.M.D.)
A. Shankaranarayanan
gGE Healthcare (A.S.), Milwaukee, Wisconsin.
S. Kesari
cNeurosciences (S.K., A.M.D.)
fTranslational Neuro-Oncology Laboratories (S.K.), Moores Cancer Center; University of California, San Diego, La Jolla, California
C.R. McDonald
dPsychiatry (C.R.M., A.M.D.)
eMultimodal Imaging Laboratory (N.S.W., N.F., J.M.K., H.M.G., C.R.M., A.M.D.)
A.M. Dale
bDepartments of Radiology (N.S.W., N.F., R.C., J.M.K., A.M.D.)
cNeurosciences (S.K., A.M.D.)
dPsychiatry (C.R.M., A.M.D.)
eMultimodal Imaging Laboratory (N.S.W., N.F., J.M.K., H.M.G., C.R.M., A.M.D.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
American Journal of Neuroradiology
Vol. 34, Issue 9
1 Sep 2013
Advertisement
P.D. Kothari, N.S. White, N. Farid, R. Chung, J.M. Kuperman, H.M. Girard, A. Shankaranarayanan, S. Kesari, C.R. McDonald, A.M. Dale
Longitudinal Restriction Spectrum Imaging Is Resistant to Pseudoresponse in Patients with High-Grade Gliomas Treated with Bevacizumab
American Journal of Neuroradiology Sep 2013, 34 (9) 1752-1757; DOI: 10.3174/ajnr.A3506
Longitudinal Restriction Spectrum Imaging Is Resistant to Pseudoresponse in Patients with High-Grade Gliomas Treated with Bevacizumab
P.D. Kothari, N.S. White, N. Farid, R. Chung, J.M. Kuperman, H.M. Girard, A. Shankaranarayanan, S. Kesari, C.R. McDonald, A.M. Dale
American Journal of Neuroradiology Sep 2013, 34 (9) 1752-1757; DOI: 10.3174/ajnr.A3506
Jump to section
Related Articles
- No related articles found.
Cited By...
- Characterization of the Diffusion Signal of Breast Tissues using Multi-exponential Models
- Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with Bevacizumab
- Lessons From Anti-Vascular Endothelial Growth Factor and Anti-Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
- Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging
- Advanced Magnetic Resonance Imaging of the Physical Processes in Human Glioblastoma
- Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement